Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia

In patients with acute leukemia, detection of minimal residual disease (MRD) before allogeneic hematopoietic cell transplantation (HCT) correlates with risk of relapse. However, the level of MRD that is most likely to preclude cure by HCT is unclear, and the benefit of further chemotherapy to reduce...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Leung, Wing, Pui, Ching-Hon, Coustan-Smith, Elaine, Yang, Jie, Pei, Deqing, Gan, Kwan, Srinivasan, Ashok, Hartford, Christine, Triplett, Brandon M., Dallas, Mari, Pillai, Asha, Shook, David, Rubnitz, Jeffrey E., Sandlund, John T., Jeha, Sima, Inaba, Hiroto, Ribeiro, Raul C., Handgretinger, Rupert, Laver, Joseph H., Campana, Dario
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2012
Teme:
Transplantation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3398757/
https://ncbi.nlm.nih.gov/pubmed/22517895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-02-409813
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki